Stockscreener 앱 받기
0.00
100.00%
-0.157
전일 마감가:
$0.157
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$11.00M
수익:
$1.16M
순이익/손실:
$-39.74M
주가수익비율:
0.00
EPS:
-0.62
순현금흐름:
$-35.02M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$0.4477
Glycomimetics Inc Stock (GLYC) Company Profile
명칭
Glycomimetics Inc
전화
240-243-1201
주소
9708 MEDICAL CENTER DRIVE, ROCKVILLE, MD
GLYC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GLYC
Glycomimetics Inc
|
0.00 | 11.00M | 1.16M | -39.74M | -35.02M | -0.62 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Glycomimetics Inc Stock (GLYC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-25 | 개시 | Jefferies | Buy |
| 2025-08-11 | 개시 | H.C. Wainwright | Buy |
| 2025-07-14 | 개시 | Wedbush | Outperform |
| 2025-06-25 | 개시 | Stifel | Buy |
| 2025-03-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-07-26 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-12-22 | 개시 | CapitalOne | Overweight |
| 2021-11-12 | 업그레이드 | Jefferies | Hold → Buy |
| 2019-11-14 | 개시 | ROTH Capital | Buy |
| 2019-08-05 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-08-05 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2019-08-05 | 다운그레이드 | SunTrust | Buy → Hold |
| 2019-04-12 | 개시 | Piper Jaffray | Overweight |
| 2018-12-18 | 개시 | H.C. Wainwright | Buy |
| 2016-07-26 | 개시 | SunTrust | Buy |
| 2015-03-17 | 재확인 | Stifel | Buy |
모두보기
Glycomimetics Inc 주식(GLYC)의 최신 뉴스
Predicting GlycoMimetics Inc. trend using moving averagesGap Up & Real-Time Buy Signal Alerts - newser.com
Long term hold vs stop loss in GlycoMimetics Inc.Weekly Profit Analysis & Low Risk Entry Point Guides - newser.com
Identifying reversal signals in GlycoMimetics Inc.July 2025 Earnings & Low Risk Entry Point Guides - newser.com
GlycoMimetics Inc. stock prediction for this weekEarnings Summary Report & Daily Oversold Stock Bounce Ideas - newser.com
How interest rate cuts could boost GlycoMimetics Inc. stock2025 Volatility Report & Weekly Consistent Profit Watchlists - newser.com
How to forecast GlycoMimetics Inc. trends using time series2025 Bull vs Bear & Verified Entry Point Signals - newser.com
What machine learning models say about GlycoMimetics Inc.Market Risk Analysis & Safe Entry Zone Tips - newser.com
Best data tools to analyze GlycoMimetics Inc. stockTrade Signal Summary & Growth Oriented Trading Recommendations - newser.com
Why GlycoMimetics Inc. stock remains undervaluedGap Down & Stock Timing and Entry Methods - newser.com
Real time pattern detection on GlycoMimetics Inc. stockWeekly Trend Recap & High Accuracy Swing Trade Signals - newser.com
Earnings visualization tools for GlycoMimetics Inc.2025 Geopolitical Influence & Real-Time Chart Pattern Alerts - newser.com
Is GlycoMimetics Inc. stock attractive for growth ETFs2025 Investor Takeaways & Verified Trade Idea Suggestions - newser.com
Published on: 2025-10-31 00:29:32 - newser.com
Cantor Fitzgerald Initiates Coverage of GlycoMimetics (GLYC) with Overweight Recommendation - MSN
How GlycoMimetics Inc. stock compares to growth peers2025 Growth vs Value & Step-by-Step Swing Trade Plans - fcp.pa.gov.br
Published on: 2025-10-27 20:15:28 - newser.com
Can GlycoMimetics Inc. stock deliver surprise earnings beatMarket Risk Analysis & Reliable Price Breakout Alerts - Fundação Cultural do Pará
Glycomimetics Inc (GLYC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):